Novo Nordisk A/SNVO
Price as of · delayed, not real-time
A Denmark-based pharmaceutical manufacturer focused on diabetes care, obesity treatments, and other chronic diseases, with a portfolio anchored by insulin products and GLP-1 therapies such as Ozempic and Wegovy. The company generates the majority of its revenue from treatments for diabetes and weight management, making it a central player in the rapidly expanding metabolic disease market. Investors closely monitor prescription growth, pricing dynamics, and clinical pipeline developments given the outsized earnings impact of its obesity franchise.
Congressional Interest in Novo Nordisk A/S (NVO)
13 members of Congress have disclosed 133 trades in Novo Nordisk A/S (NVO), a Healthcare company. The buy/sell breakdown shows 30 purchases versus 20 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading NVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-03-30 | Alan Armstrong | buy | $15K-$50K |
| 2026-03-13 | Rohit Khanna | buy | $1K-$15K |
| 2026-02-13 | Rohit Khanna | buy | $1K-$15K |
| 2025-10-31 | Lisa McClain | sell | $1K-$15K |
| 2025-10-30 | Lisa McClain | buy | $1K-$15K |
| 2025-10-30 | Lisa McClain | sell | $1K-$15K |
| 2025-10-15 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-09-11 | Lisa McClain | buy | $1K-$15K |
| 2025-09-11 | Lisa McClain | buy | $1K-$15K |
| 2025-08-28 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-08-19 | Marjorie Taylor Greene | buy | $15K-$50K |
| 2025-08-04 | Scott Franklin | buy | $1K-$15K |
| 2025-08-04 | Scott Franklin | buy | $1K-$15K |
| 2025-08-04 | Lisa McClain | sell | $1K-$15K |
| 2025-08-04 | Scott Franklin | buy | $15K-$50K |
| 2025-08-04 | Scott Franklin | buy | $1K-$15K |
| 2025-07-10 | Lisa McClain | sell | $1K-$15K |
| 2025-06-16 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2025-06-09 | Lisa McClain | buy | $1K-$15K |
| 2025-05-08 | Laurel Lee | sell | $1K-$15K |
| 2025-03-27 | Scott Franklin | buy | $1K-$15K |
| 2025-03-27 | Scott Franklin | buy | $15K-$50K |
| 2025-03-20 | Byron Donalds | sell | $1K-$15K |
| 2025-03-20 | Byron Donalds | sell | $1K-$15K |
| 2024-12-23 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2024-12-23 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2024-11-04 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2024-10-29 | Valerie Hoyle | buy | $1K-$15K |
| 2024-10-21 | MICHAEL T. MCCAUL | buy | $15K-$50K |
| 2024-09-04 | John James | sell | $1K-$15K |
| 2024-08-26 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2024-08-26 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2024-08-09 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2024-08-09 | MICHAEL T. MCCAUL | buy | $15K-$50K |
| 2024-07-12 | Rohit Khanna | buy | $1K-$15K |
| 2024-05-28 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2024-04-24 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2024-04-24 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2024-04-23 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2024-04-23 | MICHAEL T. MCCAUL | sell | $50K-$100K |
| 2024-04-09 | John James | sell | $1K-$15K |
| 2024-01-19 | Thomas H Tuberville | sell | $15K-$50K |
| 2023-12-06 | Rohit Khanna | sell | $1K-$15K |
| 2023-11-10 | John James | buy | $1K-$15K |
| 2023-07-12 | Daniel Goldman | sell | $100K-$250K |
| 2023-07-10 | Daniel Goldman | sell | $250K-$500K |
| 2023-06-12 | Rohit Khanna | buy | $1K-$15K |
| 2022-10-07 | Byron Donalds | buy | $1K-$15K |
| 2022-10-07 | Byron Donalds | sell | $1K-$15K |
| 2021-09-16 | KATHERINE CLARK | sell | $1K-$15K |